Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study
Titel:
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study
Auteur:
Craig, Timothy J Levy, Donald S Reshef, Avner Lumry, William R Martinez-Saguer, Inmaculada Jacobs, Joshua S Yang, William H Ritchie, Bruce Aygören-Pürsün, Emel Keith, Paul K Busse, Paula Feuersenger, Henrike Alexandru Bica, Mihai Jacobs, Iris Pragst, Ingo Magerl, Markus